Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Early hair loss may indicate prostate issues.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Men with testicular cancer were less likely to experience baldness and severe acne.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Being obese and eating too many calories may increase the risk of kidney cancer, but physical activity doesn't seem to affect this risk.

Heavy metals might contribute to hair loss in Telogen Effluvium.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Some plants may help with hair growth and have fewer side effects than synthetic drugs, but more research is needed to confirm their effectiveness.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Frailer men have a higher risk of worsening prostate problems and serious health events needing hospital care.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

New treatments like nanotechnology show promise in improving skin cancer therapy.